Related Experiment Video

Updated: Jul 20, 2026

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

Differential inhibition of TRAIL-mediated DR5-DISC formation by decoy receptors 1 and 2

Delphine Mérino1, Najoua Lalaoui, Alexandre Morizot

  • 1INSERM, U517, Univ. Bourgogne, Dijon F-21000, France.

Molecular and Cellular Biology
|September 19, 2006
PubMed

Insights

Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) binding to decoy receptors DcR1 and DcR2 inhibits cancer cell death through distinct mechanisms. DcR1 sequesters TRAIL in lipid rafts, while DcR2 disrupts death-inducing signaling complex assembly.

Area of Science:

  • Molecular biology
  • Cellular signaling
  • Cancer research

Background:

  • Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) triggers cancer cell death via apoptosis.
  • TRAIL signaling is modulated by death receptors (DR4, DR5) and decoy receptors (DcR1, DcR2).

Purpose of the Study:

  • To elucidate the distinct mechanisms by which decoy receptors DcR1 and DcR2 inhibit TRAIL-induced apoptosis.
  • To understand the regulatory complexity of TRAIL signaling.

Main Methods:

  • Investigated the interaction of TRAIL with decoy receptors.
  • Analyzed the role of DcR1 and DcR2 in the formation and function of the death-inducing signaling complex (DISC).
  • Examined the impact on caspase activation and receptor recruitment.

Main Results:

  • DcR1 inhibits TRAIL-induced apoptosis by sequestering TRAIL within lipid rafts, preventing DISC assembly.
  • DcR2 inhibits apoptosis by co-recruiting with DR5 into the DISC, blocking initiator caspase activation.
  • DcR2 also prevents DR4 recruitment into the DR5 DISC, adding another layer of regulation.

Conclusions:

  • DcR1 and DcR2 employ unique strategies to inhibit TRAIL-mediated apoptosis.
  • These findings reveal intricate regulatory mechanisms governing TRAIL signaling pathways.
  • Understanding these pathways may offer new therapeutic strategies for cancer treatment.

More Related Videos

Generation, Purification, and Characterization of Cell-invasive DISC1 Protein Species14:33

Generation, Purification, and Characterization of Cell-invasive DISC1 Protein Species

Published on: August 30, 2012

Tracking Drug-induced Changes in Receptor Post-internalization Trafficking by Colocalizational Analysis07:48

Tracking Drug-induced Changes in Receptor Post-internalization Trafficking by Colocalizational Analysis

Published on: July 3, 2015

Related Concept Videos

Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
The Two-State Receptor Model01:29

The Two-State Receptor Model

The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...